ReviewPharmacological reports : PR2020

Cepharanthine: a review of the antiviral potential of a Japanese-approved alopecia drug in COVID-19.

Moshe Rogosnitzky et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.